AMSTERDAM, the Netherlands, December 12 /PRNewswire/ --

- Forty-five Prestigious Journals to be Launched on ScienceDirect in Response to Customer Demand

Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced that 45 French-language medical journals from Elsevier Masson will be available on ScienceDirect beginning January 3, 2008.

ZUG, Switzerland, December 12 /PRNewswire/ -- Swiss Hawk AG's portfolio company Vitaboost International BV launches its new website with online shop today. The new online shop enables customers from all over Europe to order Vitaboost products online. In addition, Vitaboost products will be available in stores from Friday 14th December. The first Vitaboost product is the "Vitaboost Activator", a healthy energy drink product for everyday use with a base of orange, grape and lime juice enriched with Ginkgo Biloba, Taurin, Ginseng, Vitamin B Complex, Vitamin C, Caffeine, Schisandra and Guarana. Check out http://www.vitaboost.com for more information.

About Vitaboost International BV

FRIMLEY, England, December 12 /PRNewswire/ --

- Approximately 78% of Beta-thalassaemia Patients had Decreases in Cardiac Iron and 90% had Decreases in Liver Iron After Six Months, Interim Data Show(1)

- Study in Sickle Cell Disease (SCD) Patients With Iron Overload Showed Continued Safety and Efficacy Over Two Years(2)

- Safety and Efficacy Demonstrated in Lower-Risk Myelodysplastic Syndromes (MDS) Patients(3)

COPENHAGEN, December 12 /PRNewswire/ --

- Summary: An IND has Been Filed With the FDA for the Fourth Genmab Antibody Developed Under the Company's Collaboration With Roche.

Genmab A/S (OMX: GEN) announced today that an Investigational New Drug application (IND) for a Genmab antibody developed under the company's collaboration with Roche has been filed with the FDA by Roche. Genentech and Roche are collaborating on development of the antibody which selectively blocks the interaction of the OX40 ligand and its receptor. The companies are evaluating the antibody for the treatment of asthma. Genmab will receive a milestone payment from Roche which does not influence Genmab's financial guidance for 2007.

LONDON, December 12 /PRNewswire/ -- PRNewswire, London, December 12 - Mippin makes it easy to find, read and share content from the most popular news and blogs using your mobile internet browser. The service provides quick access to what other people are reading most during the day and with Christmas around the corner, the new Mippin Gift Guide makes it simple to see what's happening this season. Just point your phone's web browser to: http://mippin.com/giftguide to find mobile phone reviews and other gift inspirations right on your mobile phone. See PRNewswire story 1 FEATURE: Mobile Top 10 on the wire or visit http://www.mediapoint.press.net or http://www.prnewswire.co.uk.

ATTN: FEATURES EDITORS

- With Photo

BRUSSELS, Belgium, December 12 /PRNewswire/ --

The Crossroads Institute for medical education today announced it will develop new educational programs for healthcare professionals focused on improving the treatment of women with cardiovascular disease and the prevention of amputation. The announcement was made by the newly formed committee of the Crossroads Educational Research Program (CERP) at the Crossroads Institute in Brussels, Belgium, which is focused on providing the latest in medical education to advance the treatment of patients with cardiac and vascular disease and is supported by an educational grant from Abbott Vascular.